High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners
Drug Metabolism and Disposition · 2026-07 · 54 (7) · 100344
DOI: 10.1016/j.dmd.2026.100344 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Metabolism and Disposition, 2026-07. Verfasst von Yudong Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP2E1, Escherichia coli. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, University of Michigan, National Institute of General Medical Sciences.
Abstract (Originalsprache)
Few liver microsomal cytochromes P450 (P450s), especially human P450s, are recombinantly expressed in bacteria as full-length proteins. Lack of the N-terminal membrane anchor hinders studies of the interactions of microsomal P450s with redox partners. Herein, we describe the successful expression of full-length human CYP2E1, referred to as hCYP2E1FLAL, in bacteria to give a yield of ∼704 nmol/L culture. This high-level expression was achieved due to the codon optimization strategy employed to reduce free energy for translation and growth temperature. The expressed hCYP2E1FLAL was purified with a single affinity column and contained no P420, the inactive form of P450. Compared with N-terminal truncated human CYP2E1 (hCYP2E1dH), hCYP2E1FLAL exhibits elevated enzyme activity toward prototypic substrates, chlorzoxazone and p-nitrophenol, with ∼2-fold increase in kcat in the absence of cytochrome-b5 (cyt b5). The elevated enzyme activity is more pronounced in the presence of cyt b5, with a 4.3-fold increase for chlorzoxazone and a 2.5-fold increase for p-nitrophenol. Moreover, hCYP2E1FLAL binds NADPH-cytochrome P450 oxidoreductase (POR) more tightly with an apparent KM of 0.36 ± 0.026 μM, compared to 1.2 ± 0.13 μM for truncated hCYP2E1dH. Interestingly, the presence of cyt b5 further decreased the KM of POR to 0.13 ± 0.014 μM for hCYP2E1FLAL as opposed to 0.40 ± 0.041 μM for hCYP2E1dH, suggesting that cyt b5 promotes the interactions of CYP2E1 with POR. Taken together, these results suggest that the N-terminal transmembrane anchor enhances hCYP2E1-catalyzed reactions, likely by favorable interactions with POR and cyt b5 to form active complexes with redox partners, and that the full-length enzyme is the appropriate form for further redox partner interaction studies in membrane systems. SIGNIFICANCE STATEMENT: In vitro drug metabolism by CYP2E1 is often inferred from rodent CYP2E1 or truncated human CYP2E1 due to the lack of recombinant full-length human CYP2E1. This study developed a high-level bacterial expression of full-length human CYP2E1. Comparative studies of full-length and truncated human CYP2E1 in hydroxylation of chlorzoxazone and p-nitrophenol reveal that the N-terminal anchor of human CYP2E1 is critical for promoting interactions with NADPH-cytochrome P450 oxidoreductase and cytochrome-b5 and, hence, enzyme activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan.
- Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: osawa@umich.edu.
- Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: haom@umich.edu.
Förderung
- NIGMS NIH HHS
- University of Michigan
- National Institute of General Medical Sciences
- Biomedical Research Council
- Medical School, University of Michigan
- National Institutes of Health
Zitieren
APA
Sun, Y., Amunugama, P., Osawa, Y., & Zhang, H. (2026). High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners. Drug Metabolism and Disposition, 54(7), 100344. https://doi.org/10.1016/j.dmd.2026.100344
Vancouver
Sun Y, Amunugama P, Osawa Y, Zhang H. High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners. Drug Metabolism and Disposition. 2026;54(7):100344. doi:10.1016/j.dmd.2026.100344
BibTeX
@article{Sun2026,
author = {Sun, Yudong and Amunugama, Praveen and Osawa, Yoichi and Zhang, Haoming},
title = {High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {7},
pages = {100344},
doi = {10.1016/j.dmd.2026.100344}
}
EUVIMED